3Lip G Y,Tello-Montoliu A.Management of atrial fibrillation.Heart,2006,92 (8):1177-1182. 被引量：1
4Madrid AH,Bueno MG,Rebollo.et al.Use of irbesartan to maintain sinus rhyhm in patients with long-lasting persistent atria fibrillation.Circulation,2002,106 (3):331-336. 被引量：1
5Vermes E,Tardif JC,Bourassa MG,et al.Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction.Circulation,2003,107 (23):2926-2931. 被引量：1
6David E,Dostal and Kenneth M,Baker.The cardiac reninangiotensin system:Conceptual,ora regulator of cardiac function.Circ Res,1999,85 (6):643-650. 被引量：1
7Surks M I, Ortiz E, Daniels G H, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and man- agement[J]. JAMA, 2004, 291: 228. 被引量：1
8Auer J, Seheibner P, Mische T, et al. Subclinical hyperthy- roidism as a risk factor for atrial fibrillation[J]. Am Hearl J, 2001, 142: 838. 被引量：1
9Rosario P W. Bone and Heart Abnormalities of Subclinical Hyperthyroidism in Women Below the Age of 65 Years [ J ]. Arq Bras Endocrinol Metabol, 2008, 52(9) : 1448. 被引量：1
10Anand K,Mooss AN,Hee TT,ef al. Meta - analysis: inhibition of re-nin -angiotens in system prevents new - onset atrial fibrillation[ J].Am Heart .2006; 152:217 -222. 被引量：1
